News • 28-6-2016

EPCCS signed Mexico Declaration on Circulatory Health

Among many other co-signers, Prof. Richard Hobbs, as chairmain of EPCCS, signed the Mexico Declaration on Circulatory Health, which was published as a letter on the Times online, as an international call to action to tackle one of the most pressing health issues of our time. Read more

Soft drinks increase the risk for coronary atherosclerosis

27-6-2016 • Chun S et al., Am Heart J 2016
In Korean people, higher sugar-sweetened carbonated beverage consumption was associated with asymptomatic coronary atherosclerosis as measured by coronary artery calcium. Read more

Statin treatment effective and safe in very young HeFH subjects

20-6-2016 • Langslet G et al., J Clin Lipidol. 2016
Open-label prospective 3-year study of atorvastatine in HeFH subjects aged 6-15 years showed that treatment was safe, effective and did not affect growth or maturation. Read more

Maternal and pregnancy factors affect risk of future T2DM in women with gestational diabetes

20-6-2016 • Rayanagoudar G et al., Diabetologia 2016
Several maternal and pregnancy factors are associated with a higher risk of developing T2DM in women with gestation diabetes. They can be used for personal risk quantification. Read more
News • 15-6-2016

EHRA practical guide for non-vitamin K antagonist anticoagulants in non-valvular AF patients updated

The European Heart Rhythm Association (EHRA) published a rewritten, updated version of the previously published (2013) guidelines for NOACs in non-valvular AF patients. Read more
News • 15-6-2016

Highest CV mortality risk for T2DM patients previously hospitalised with heart failure

ADA 2016 Evaluation CV mortality risk for 5380 EXAMINE patients with T2DM on alogliptin/placebo, showed that risk for patients experiencing a non-fatal CV was especially increased for HHF patients. Read more
News • 28-6-2016

EPCCS well represented at WONCA congress

Representatives of the EPCCS board organised three well-attended sessions at WONCA Europe 2016 in Copenhagen, Denmark, covering topics ranging from heart failure to the pros and cons of statins. Read more

Electronic cigarette smoking exerts unfavourable effect just like tobacco cigarette smoking

21-6-2016 • Vlachopoulos C et al. JACC 2016
Research letter shows that smoking of an electronic cigarette affects BP and aortic stiffness to a similar extent as does tobacco cigarette smoking. Read more

HF diagnosis often unjustified in primary care

20-6-2016 • Valk MJ et al., BJGP 2016
An expert panel that retrospectively identified HF patients according to ESC guidelines could not confirm one-third of the cases that were HF-diagnosed by the general practitioner. Read more

CV event reduction with GLP-1 analogue in patients with type 2 diabetes

16-6-2016 • Marso SP et al., N Engl J Med 2016
ADA 2016 In T2DM patients at high CV risk, liraglutide on top of standard therapy was associated with lower rates of CV events and mortality, compared with placebo in the LEADER outcome trial. Read more
News • 15-6-2016

Lower blood sugar with DPP-4 inhibitor in adults with type 2 diabetes at risk for renal impairment

ADA 2016 In 360 patients with T2DM and albuminuria, linagliptin significantly reduced blood glucose levels, is well tolerated and does not need dose adjustment in patients at risk for kidney impairment. Read more
News • 15-6-2016

All age groups have CV benefit from SGLT2 inhibition in type 2 diabetes

ADA 2016 New empagliflozin data show that reduced risk for cardiovascular death was consistent across age groups in adults with type 2 diabetes. Read more

Upcoming meetings

Meeting reports & resources

EPCCS 2017 Report of the Cardiovascular Summit held in Dublin, Ireland
EPCCS Guidance Documents Evidence- and meeting-based guidance for primary care
EPCCS 2015 Report of 8th Annual EPCCS meeting held in Prague.
EPCCS 2014 Report of 7th Annual EPCCS meeting held in Brussels.
All meeting reports...